SLN
OTC MARKETS · Biotechnology
Silence Therapeutics PLC
$19.80
+0.03 (+0.15%)
Performance
1D
—
1W
+0.35%
1M
+120.49%
3M
+37.98%
6M
+217.82%
1Y
+186.13%
YTD
+221.95%
Open$19.76
Previous Close$19.77
Day High$19.82
Day Low$19.76
52W High$6.38
52W Low$1.06
Volume—
Avg Volume1.4K
Market Cap1.28B
P/E Ratio—
EPS$-0.48
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$14.46
Above
SMA 200
$9.63
Above
RSI (14)
60
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2026 | |
|---|---|
| Revenue | 14.75M |
| Net Income | -31,237,785 |
| Profit Margin | -231.4% |
| EBITDA | -35,003,763 |
| Free Cash Flow | — |
| Rev Growth | +315.5% |
| Debt/Equity | 2.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |